Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01116648 |
|---|---|
| Brief Title: | Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer |
| First Submitted : | April 29, 2010 |
| First Submitted that Met QC Criteria : | May 4, 2010 |
| First Posted : | May 5, 2010 (Estimate) |
| Results First Submitted : | February 4, 2020 |
| Results First Submitted that Met QC Criteria : | July 7, 2020 |
| Results First Posted : | July 22, 2020 |
| Last Update Submitted that Met QC Criteria : | March 8, 2024 |
| Last Update Posted : | April 8, 2024 |